PreciControl Anti-HBc II - Hepatitis B virus core total antibody IVD, control
Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
28-05-2019
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
Roche Diagnostics Australia Pty Limited
Klassi:
Class 4
Manifatturat minn:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Żona terapewtika:
41984 - Hepatitis B virus core total antibody IVD, control
Indikazzjonijiet terapewtiċi:
PreciControl Anti - HBc II is a ready-for-use control serum based on human serum both in the negative and positive concentration range. The controls are used for monitoring the accuracy of the Elecsys Anti - HBc II immunoassay. PreciControl Anti - HBc II is used for quality control of the Elecsys Anti - HBc II immunoassay on the Elecsys and cobas e immunoassay analysers.
L-istatus ta 'awtorizzazzjoni:
A
Data ta 'l-awtorizzazzjoni:
2017-12-22
